Cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) and programmed cell death protein 1 (PD-1) are two inhibitory receptors expressed by T cells that have become therapeutic targets to mitigate the immunosuppressive tumor environment and promote antitumor immunity. The gene discussed is PDCD1; the disease is neoplasm.